baber/WOPTO huggingface dataset:
Patent DK-1240079-T3 (DK)
Inventor: HAGEN ELDAR
IPC: F21Y101/00
Filed: 2000-12-20
Granted: 2006-12-11
Abstract: A lighting device for installation in a substantially plane surface, comprising at least one lamp device that emits light essentially in a light direction which forms an angle with an exit face of a light refracting means in the lamp device. The lamp device comprises a light source that emits light towards an incident face of the light refracting means, where the light refracting means has a longitudinal direction coincident with the light direction, and where the exit face is approximately parallel to the substantially plane surface. The exit face is set a slight angle of inclination relative to the substantially plane surface, the angle and the angle of inclination in combination causing light from the light source to be brought to an emergent angle above the face that satisfies pre-set requirements for light intensity close to the surface.A prism is also described wherein at least the edge formed between the exit face of the prism and a side face which forms an acute angle with the exit face is rounded.
Patent DK-1145961-T3 (DK)
Inventor: SATO SEIJI
IPC: B65B61/24
Filed: 2001-04-12
Granted: 2004-06-01
Abstract: A container forming device comprises a container conveyor (21) having a plurality of holders (34) and intermittently drivable so as to halt the holders at an ear bonding station in succession, an upper ear pressing member (61) disposed above the ear bonding station so as to be movable upward or downward for pressing upper ears against an upper wall of a container body, and a pair of lower ear pressing members (62) arranged at opposite sides of the ear bonding station so as to be openable or closable for pressing lower ears against respective side walls of the container body. Each of the holders comprises a bottom plate (51) extending in parallel to a container transport path, and a side plate (52) projecting upward from the bottom plate and extending orthogonal to the container transport path. The bottom plates of each pair of adjacent holders are adapted to place the container body thereon, with the side plates of the adjacent holders holding the container body therebetween. The device further comprises lock members (91) for locking the side plates of the adjacent holders so as not to permit upper ends of the side plates to move away from each other when the upper ear pressing member and the lower ear pressing members press the ears against the container body. <IMAGE>
Patent DK-1138186-T3 (DK)
Inventor: KLEINKNECHT CHRISTOPH
IPC: A01C7/20
Filed: 2001-03-27
Granted: 2004-03-15
Abstract: The seed planting device comprises an inlet orifice (21) through which an air flow transporting the seeds arrives. There is an outlet orifice (22) through which the seeds are planted in the ground and a separation device (23) for separating seeds from the transporting air flow. The separator comprises a grille (24) located in the extension of the air flow inlet orifice so that a maximum of air escapes through it and the seeds are retained.
Patent DK-1287142-T3 (DK)
Inventor: MUELLER HANS WERNER
IPC: C12N1/15
Filed: 2001-06-01
Granted: 2006-03-13
Abstract: The invention concerns a nucleic acid molecule which includes a nucleic acid sequence coding for a chemokine, a neuropeptide precursor or at least one neuropeptide, as well as a host cell which contains this nucleic acid molecule. In addition the invention concerns a polypeptide molecule which functions as chemokine or neuropeptide or contains at least one neuropeptide, as well as fragments thereof which include at least one neuropeptide, and a procedure for the manufacture of the polypeptide molecule or of a fragment thereof. In addition the invention concerns antibodies, demonstration procedures and test-kits as well as pharmaceutical preparations. The purpose on which present invention is based is to make new means available which can be put to use aimed at the diagnosis and/or treatment of diseases which are associated with a defect of the SDF-1 factor or its receptor (CXCR4).
Patent DK-1299201-T3 (DK)
Inventor: BOCK RALF
IPC: B22D18/04
Filed: 2001-07-07
Granted: 2005-06-13
Abstract: In a slide valve closure for the casting of a metal melt a slider plate and a stationary closure part are braced against each other by means of spring units or by other means. There is provided a casing framework attachable to a mould or the like, in which is fixed a detachable casing part on which the spring units are held and in which the stationary closure part and the slider plate can be accommodated. This allows safe operation and simple and rapid mounting and dismounting of the slide valve closure.
Patent DK-1315518-T3 (DK)
Inventor: COLACO CAMILO ANTHONY LEO SELWYN
IPC: A61K39/106
Filed: 2001-09-04
Granted: 2010-04-19
Abstract: The present invention provides a vaccine comprising a microbial pathogen, wherein the microbial pathogen is subjected to a stress inducing stimuli. The stress inducing stimuli can be heat or osmotic stress, through preferably the microbial pathogen is genetically modified such that at least one repressor gene for a heat shock protein gene is inactivated, thus allowing the constitutive expression of heat shock proteins. In particular the use of heat shock protein repressor mutant bacteria is shown to be effective for inducing immunity when comprised within vaccines of the present invention. The present invention further provides a method for producing a vaccine comprising stressed induced microbial pathogens and further the use of the heat shock protein repressor deletion mutant microbes as vaccine vectors which can be additionally allow the expression of heterologous antigen fragments.
Patent DK-1315715-T3 (DK)
Inventor: PANDEY ANJALI
IPC: A61P9/08
Filed: 2001-08-17
Granted: 2008-11-17
Abstract: The present invention relates to nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which have inhibitory activity on the phosphorylation of kinases, which inhibits the activity of such kinases. The invention is also related to a method of inhibiting kinase and treating disese states in a mammal by inhibiting the phosphorylation of kinases. In a particular aspect the present invention provides nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which inhibit phosphorylation of a PDGF receptor to hinder abnormal cell growth and cell wandering, and a method for preventing or treating cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis.
Patent DK-1346041-T3 (DK)
Inventor: GEFTER MALCOLM L
IPC: A61K47/48
Filed: 2001-11-27
Granted: 2007-07-02
Abstract: The present invention provides therapeutic agents suitable for treating an amyloidogenic disorder, as well as pharmaceutical compositions comprising the therapeutic agents and a pharmaceutically acceptable carrier. The present invention also provides methods of treating an amyloidogenic disorder, e.g., Alzheimer's disease, in a subject by administering to the subject a therapeutically effective amount of one or more of the compounds of the invention.
Patent DK-1316997-T3 (DK)
Inventor: FRANK THOMAS
IPC: H01L25/07
Filed: 2002-11-27
Granted: 2008-02-25
Abstract: The device has a base body, a substrate carrying semiconducting components and contact elements for d.c. and a.c. voltage connections and a d.c. intermediate circuit board. At least one contact has protrusions and the counterpart has deformable dimples whose base area is only partly covered by the protrusions. The dimples are deformed by the protrusions so their common contact surface is at least one fifth of the base of a dimple. <??>The device has a base body, a substrate carrying semiconducting components connected correctly for the circuit and contact surfaces, contact elements for d.c. and a.c. voltage connections for contacting the contact surfaces and a d.c. intermediate circuit board. At least one contact has protrusions (11) and the counterpart has deformable dimples (4) whose base area is only partly covered by the protrusions. The dimples are deformed by the protrusions so that the common contact surface (12) of a dimple and protrusion is at least one fifth of the base of a dimple.
Patent DK-1228728-T3 (DK)
Inventor: STEWART JOHN
IPC: A47G9/10
Filed: 2002-01-31
Granted: 2006-08-28
Abstract: The invention relates to a sleeping means which can be moved between the storage and in-use conditions. The sleeping means typically comprise a deformable mattress which is inflatable and which can be located within with an envelope formed of sheet material and, attached to the sheet material is a cover portion which, with the sheet material of the mattress defines a sleeping area into which a person can move. The cover portion can be permanently attached to the sleeping means but further edges of the same can be selectively attached using zips or other fastening means. An additional portion of sheet material can be provided which can be selectively used to act as a storage pocket.
Patent DK-1411932-T3 (DK)
Inventor: STRAUB ALEXANDER
IPC: A61K31/421
Filed: 2002-06-07
Granted: 2010-05-31
Abstract: The invention relates to combinations of A) oxazolidinones of formula (I) and B) other active ingredients, to a method for producing said combinations and to the use thereof as medicaments, in particular for the treatment and/or prophylaxis of thrombo-embolic diseases.
Patent DK-1427394-T3 (DK)
Inventor: BOLTON ANTHONY E
IPC: A61K31/661
Filed: 2002-09-13
Granted: 2007-06-11
Abstract: Mammalian patients suffering from post-wounding trauma, or about to or likely to suffer such trauma (by surgical treatment, or by suffering unanticipated accidental injuries, battle injuries or the like) are treated to lessen the severity of or accelerate the recovery from such subsequently sustained trauma, by administering to the patient immune system-modifying entities, each comprising a body of a size similar to an apoptotic mammalian cell or apoptotic body, and having exposed on its surface phos-pho-amino acid groups, the entities being capable of being taken up by cells of the patient=s immune system with accompanying beneficial effects including inhibition of pro-inflammatory cytokines and/or promotion of anti-inflammatory cytokines. The entities may be phosphatidylserine-presenting liposomes or natural products, beads carrying phospho-serine or phosphatidylserine side groups, apoptotic cells or apoptotic bodies, generally of size 50 nanometers to 500 microns, and administered to contact a patient=s immune system (e.g. intramuscularly) in amounts which affect but do not overwhelm the patient=s immune system.
Patent DK-1398046-T3 (DK)
Inventor: VOGT SEBASTIAN DR
IPC: A61L31/16
Filed: 2003-08-29
Granted: 2005-10-10
Abstract: A composite (A) comprises: (1) a homogeneous mixture (A1) of at least one hydrophobic, nonionic polymer (I) and at least one hydrophilic polyether (II); and (2) at least one antibiotic salt (III) that is sparingly soluble in water. A composite (A) comprises: (1) a homogeneous mixture (A1) of at least one hydrophobic, nonionic polymer (I) and at least one hydrophilic polyether (II); and (2) at least one antibiotic salt (III) that is sparingly soluble in water. (I) is PVC, optionally post-chlorinated; poly(vinylidene chloride or fluoride), poly(vinyl fluoride) or a copolymer of vinyl chloride with at least one nonionic monomer. (III) is the salt of an aminoglycoside, lincosamide, tetracycline, glycopeptide or quinolone antibiotic, or of chlorhexidine. (A) may also include (i) an antibiotic (IV; aminoglycoside, lincosamide, beta-lactam or tetracycline) that is freely soluble in water and (ii) one or more organic auxiliaries.
Patent DK-1474288-T3 (DK)
Inventor: BRINKMANN PETER
IPC: B32B3/28
Filed: 2003-07-04
Granted: 2005-10-17
Abstract: The invention relates to flexible band material (10) which comprises at least one supporting layer (12) and a covering layer (14). Said flexible band material (10) is embodied in the form of a plurality of folds (16) whose edges cross the direction of elongation (18) and are disposed substantially in a parallel position with respect to each other. The aim of the invention is to develop a water-resistant band material which is less expensive and less brittle in comparison with known materials. The supporting layer (12) is provided with organic material fibres, the covering layer (14) is embodied in the form of a sheet of ductile material, and the folds are embodied in the form of microscopic folds (16). In the preferred variant, the supporting layer (12) is embodied in the form of a nonwoven fabric and a textile fabric or a stitch fabric. The covering layer can be embodied in the form of at least two layers. The invented band material (10) can be also embodied in the form of a coating (20) made of ductile material.
Patent DK-1561728-T3 (DK)
Inventor: ALLERDISSE RENE
IPC: C09C1/30
Filed: 2004-12-28
Granted: 2007-04-10
Abstract: Hydrophobically precipitated silica with a BET surface area of less than 110 m 2>/g, a cetyl trimethyl ammonium chloride (CTAB) surface area of less than 150 m 2>/g, a BET/CTAB ratio of less than 3, a carbon content of more than 3.1% and a pH of more than 9, is new. Independent claims are also included for: (1) producing hydrophobic precipitated silica by precipitating silica, filtering the precipitate, diluting the filter cake with water, adding a base, drying the suspension, heat-treating the product at a temperature above 150[deg]C and grinding the product, where a hydrophobizing agent is added to the silica or to a dispersion or filter cake comprising the silica; (2) hydrophobic precipitated silica produced as above.
Patent DK-1610743-T3 (DK)
Inventor: SHAW HELEN LOUISE
IPC: A61F13/02
Filed: 2004-04-07
Granted: 2009-06-08
Abstract: A wound dressing for post-operative sites requiring drainage includes a thin film or film/foam laminate layer with an adhesive applied to one surface thereof and an absorbent layer positioned on the adhesive surface. The dressing has an aperture to accommodate a drainage tube and a slit extending from the aperture to an outer edge of the dressing.
Patent DK-1610007-T3 (DK)
Inventor: KOPPENHOEFER PETER
IPC: F16B5/02
Filed: 2005-06-23
Granted: 2010-09-06
Abstract: A tightening system for secure connection of at least two elements (1, 2) with one another has a connecting member (3, 3') extending in openings provided in the elements and having two opposite ends (4, 5) with at least one of the ends (4) adapted to extend outwardly beyond at least one of the elements. A spacer member (6) is arranged rotatably between the elements (1, 2), holding means (7) are arranged at the other end of the connecting member (3, 3'), and a tightening member (11) is arranged on the at least one end of the connecting member. The spacer member (6) is freely rotatable on the connecting member (3, 3') to prevent cutting of the connecting member. <IMAGE>
Patent DK-1796713-T3 (DK)
Inventor: EMILIE DOMINIQUE
IPC: A61K39/00
Filed: 2005-09-09
Granted: 2011-06-27
Abstract: A pharmaceutical composition comprising at least dendritic cells modified with a molecule selected from the group consisting of: a GILZ protein or a functional fragment of at least 5 consecutive amino acids of said protein; a small interfering RNA (siRNA) targeting the GILZ transcript or an antisense oligodeoxynucleotide complementary to said transcript; and a recombinant expression vector containing a polynucleotide encoding said GILZ protein, said fragment, said siRNA or said antisense oligodeoxynucleotide complementary to said transcript and a pharmaceutically acceptable carrier. In addition, a method for treatment of autoimmune diseases, inflammatory diseases, allergies, transplant rejection and graft-versus-host disease, cancers or pathogenic microorganism infections by administering an effective amount of said pharmaceutical composition to a subject in need thereof.
Patent DK-1828772-T3 (DK)
Inventor: SOSIC ZORAN
IPC: G01N33/53
Filed: 2005-12-05
Granted: 2010-08-23
Abstract: The invention relates to the detection and quantitation of cyclodextrins and cyclodextrin derivatives in solutions comprising a protein. The invention further relates to methods of evaluating pharmaceutical preparations for the presence of residual cyclodextrins.
Patent DK-1893187-T3 (DK)
Inventor: VAN DEN PLAS DAVE
IPC: A61K31/05
Filed: 2006-06-13
Granted: 2009-03-02
Abstract: The present invention discloses a class of compounds which have an enhancing effect on peroxidase based antimicrobial compositions. The invention relates to pharmaceutical compositions for prolonged topical use comprising enhancing agents such as methoxyphenols and substituted benzylaldehydes. Examples hereof are respectively guaiacol and vanillin.
Patent DK-2030917-T3 (DK)
Inventor: PAARDEKOOPER JACOBUS GERARDUS MARIA
IPC: B65G17/08
Filed: 2008-08-22
Granted: 2011-10-03
Abstract: A conveyor belt for following a conveyance path with straight and curved conveyance path sections is constructed of module rows of a module (10) or a plurality of modules situated side by side in the transverse direction of the conveyor belt. Adjacent module rows are connected to each other by means of connecting pins (42). Each module comprises a set (15) of first aligned spaced fingers (16) with transverse aperture (40), and also a set (19) of second aligned spaced fingers (20) with transverse aperture (44), which in general are disposed in a staggered position relative to the first fingers (16). The mutual distance between at least the three outermost fingers of a set situated side by side and having the same width in a set is greater than the mutual distance between fingers situated side by side at a distance from the abovementioned at least three outermost fingers. A shorter run-in length and run-out length of a curved conveyance section of the conveyance path is achieved in this way.
Patent DK-2137804-T3 (DK)
Inventor: FRANK MICHAEL
IPC: H02K9/24
Filed: 2008-04-11
Granted: 2012-05-21
Abstract: A superconducting machine device is disclosed including a machine; a rotor including a superconductive coil; and a cooling system including at least one incline-intolerant component for cooling the coil. In at least one embodiment, at least one component is held by a carrier compensating for an incline of the machine device.
Patent DK-2326423-T3 (DK)
Inventor: LESTER JOHN
IPC: B02C13/02
Filed: 2009-06-24
Granted: 2012-06-04
Abstract: A compression device for a scrap-shredding plant, comprising at least a rotating roller element able to cooperate with a feed surface for feeding of scrap to the plant in order to grip and compress the scrap between the roller element and the feed surface. The roller element comprises a hollow tubular structure able to be dis-assembled, having semi-cylindrical cap elements reciprocally coupled during use with a rotation shaft of the rollers.
Patent DK-3004074-T3 (DK)
Inventor: MC GOWAN DAVID CRAIG
IPC: C07D401/06
Filed: 2014-05-23
Granted: 2018-01-29
Abstract: This invention relates to pyridone derivatives, processes for their preparation, phamaceutical compositions, and their use in therapy.
Patent DK-3158017-T3 (DK)
Inventor: HENDRIKS JOHANNES WILHELMUS MARIA
IPC: C09D167/08
Filed: 2015-06-19
Granted: 2018-04-03
Abstract: The present invention relates to an alkyd resin comprising the condensation product of at least the following components (A) a polybasic acid, (B) a polyhydric alcohol, and (C) a linear C12-C60 hydrocarbo monocarboxylic acid, and optionally (D) at least one component other than any of components A to C characterized in that at least a part of the polybasic acid (A) is a (optionally hydrogenated) Diels Alder adduct of citraconic acid with C4-C14 conjugated diene, a (optionally hydrogenated) Diels Alder adduct of citraconic anhydride with C4-C14 conjugated diene, a half ester of such a Diels Alder adduct and/or a diester of such a Diels Alder adduct.
Patent DK-0398217-T3 (DK)
Inventor: SHIUEY SHIAN-JAN
IPC: A61K31/593
Filed: 1990-05-14
Granted: 1994-02-14
Abstract: The use of dehydrocholecalciferal derivs. of formula (I) to make pharmaceuticals for treating diseases of the sebaceous glands is new. (Where R = H or OH; A = CC, (E)-CH=CH or CH2CH2; R'' = H or, where A = C=C, it can also be deuterium). (I) are new cpds. where R'' = deuterium.
Patent DK-0397553-T3 (DK)
Inventor: POPA JEAN-MICHEL
IPC: C01G25/02
Filed: 1990-05-04
Granted: 1994-06-27
Abstract: A microporous zirconia whose characteristic is that it has pores with a mean diameter of less than 2 nm. The invention also relates to a process for its preparation, characterised in that it consists in performing a thermohydrolysis of a zirconium salt, separating off the precipitate obtained and calcining it and in that it consists in using at least one anion which is more covalent than the hydroxyl anion before the calcination stage. The zirconia of the invention exhibits a thermal stability of its porosity, and this is particularly advantageous for catalytic applications.
Patent DK-0469446-T3 (DK)
Inventor: GULOTTA JOSEPH ANTHONY
IPC: C03C4/08
Filed: 1991-07-24
Granted: 1996-07-22
Abstract: A green tinted, ultraviolet absorbing glass is obtained by the addition of colorant to a standard soda-lime-silica base glass composition and a colorant includes less than 0.5 weight percent of cerium oxide (CeO2), greater than 0.85 weight percent of total iron expressed as Fe2O3 and a ratio of ferric iron expressed as FeO to total iron of less than 0.275. The glass has a low ultraviolet transmittance, viz., no greater than 31 percent over the wavelength range of 300 to 390 nanometers at a reference glass thickness of 3.9 millimeters. An advantage of the glass of this invention over competing ultraviolet absorbing glass is the use of larger amounts of total iron and smaller proportions of iron in the ferrous state to obtain the low ultraviolet transmittance. In this manner, the amounts of cerium oxide which is expensive is reduced.
Patent DK-0517797-T3 (DK)
Inventor: GODTFREDSEN WAGN OLE
IPC: A61K31/59
Filed: 1991-02-25
Granted: 1995-11-13
Abstract: PCT No. PCT/DK91/00056 Sec. 371 Date Jun. 11, 1992 Sec. 102(e) Date Jun. 11, 1992 PCT Filed Feb. 25, 1991 PCT Pub. No. WO91/12807 PCT Pub. Date Sep. 5, 1991.The present invention relates to the use of certain vitamin D analogues in the preparation of a pharmaceutical preparation for the treatment of acne. The preparation contains a vitamin D analogue (calcipotriol) which has only moderate activity on the calcium metabolism when compared to 1,25-(OH)2 D3, but has retained the ability to activate receptors for 1,25-(OH)2 D3 not associated with calcium absorption or bone calcium mobilization.
Patent DK-0521408-T3 (DK)
Inventor: VERTESY LASZLO DR
IPC: C07K1/113
Filed: 1992-06-26
Granted: 1997-01-20
Abstract: Demethylbalhimycin, a compound of the formula C65H71Cl2N9O24, demethylleucylbalhimycin, a compound of the formula C59H60Cl2N8O23, deglucobalhimycin, a compound of the formula C60H63Cl2N9O19, ureidobalhimycin, a compound of the formula C67H74Cl2N10O25, demethyldeglucobalhimycin, a compound of the formula C59H61Cl2N9O19, and balhimycin V, a compound of the formula C73H84Cl2N10O26, methylbalhimycin, a compound of the formula C67H75Cl2N9O24, balhimycin R, a compound of the formula C72H83Cl2N9O28, have an antibiotic action.
Patent DK-0512910-T3 (DK)
Inventor: MENTINK LEON
IPC: A23L33/20
Filed: 1992-05-04
Granted: 1996-02-05
Abstract: Low-calorie chocolate comprising:     - fat, preferably originating from cocoa,   - a sweetening filler,   - at least one emulsifying agent, - and optionally defatted dry cocoa and/or a pulverulent milk product or derivative, characterised in that it has a total fat content of less than 32%, preferably less than 31% and more preferentially still less than 29% by weight with respect to the weight of the combined abovementioned ingredients, and in that the sweetening filler is based on at least one product chosen from the group consisting of high purity crystallised maltitol, lactitol, hydrogenated isomaltulose and low-calorie saccharide polymers.